Diane Harbison
CEO, Stratified Medicine Scotland Innovation Centre

 

As CEO of the Stratified Medicine Innovation Centre, Diane brings more than 20 years’ knowledge and experience in life sciences to this role, gained from senior roles in industry, academia and in SMEs, including the European Bioinformatics Institute and Pfizer, where she was head of e-biology.

She moved into business development at Pfizer, where she was responsible for negotiating licenses and collaborations to enable access to novel technologies and assets up to the pre-proof of concept stage. She was recruited to establish the business development team at Edinburgh BioQuarter. Under her leadership, the BioQuarter business development team successfully established strategic alliances with many of the top 10 pharmaceutical companies. Subsequently as Managing Director of BioCity Scotland, she was instrumental in increasing tenant occupancy and achieving Enterprise Area Status for the site.

Dave Tudor
Vice President, Head of GMS Strategy, GSK

 

Dave joined GSK in 1992 at Worthing as a PhD Chemist from Glasgow University.  He has over 20 years’ experience with the company carrying out a number of Technical, Compliance and Manufacturing leadership roles.

In 1997 he moved to Irvine to take up a lead chemist role before coming Quality Control Manager in 1998.  He joined the site leadership team in 2001 to run Technical Development before moving to manufacturing as Actives Production Director in 2005.  During this time he completed a Masters degree in Manufacturing Leadership at Cambridge University.

In 2007 he moved to GSK House to work on a central network re-structuring project before becoming Site Director at Montrose in October 2008.  At Montrose, he led the transformation of the site to manufacture over 12 products for GSK including a major investment programme.  In 2011 he was appointed VP Primary Supply Chain with responsibility for global Active Pharmaceutical Ingredients (API) manufacture and supply, a network of GMS sites across the world including facilities in Asia and Europe.  In 2017 he was appointed VP Head of GMS Strategy with responsibility for manufacturing strategy, deployment of strategic programmes, performance management and advocacy.

Dave plays an active role with a number of Governments and is currently co-chair of the Life Sciences Scotland Industry Leadership Group.  Dave is also a member of UK Chemicals Industry Association Board.

David Scott 
Senior Director, Tepnel Pharma Services 

 

Dave is an experienced and time served member of the pharma services with a 27 years career spanning a journey from the bench to the boardroom.

Dave joined Inveresk Research in 1990 where he spent 10 years working in various roles within the company and left in 2000 to join the Medicines Testing Laboratory.  Following acquisition by Tepnel Lifes Sciences PLC, Dave has led the growth and development of the Tepnel Pharma Services brand both as an SME and as a subsidiary of a large global US healthcare and diagnostics companies.  Providing services in both GMP Quality Control and Biomarker discovery and utilisation for patient stratification and potential diagnostic use, Tepnel is based in Livingston and Manchester helping global pharmaceutical companies at both ends of the drug development pipeline.

With a commitment to the health and prosperity of the community within which he has worked Dave is a member of the Life Sciences Scotland Industry Leadership Group.  Dave is married with three children, an actor and academic and an athlete.

James Cameron
Head of Health & Life Sciences, Highlands and Islands Enterprise

 

James is currently Head of Health & Life Sciences for HIE where he has responsibility for driving sector growth, setting strategy, securing resources and engagement with partners and stakeholders.

Prior to returning to his home planet of Inverness, James had a number of roles and worked across multiple sectors with Scottish Enterprise and Scottish Development International.  James led on highly-intricate and often politically-sensitive projects.  These included Sales & Marketing Director at Edinburgh BioQuarter and projects with Amazon, Aptuit, GSK, Quintiles, Toshiba Medical, SELEX, and Bausch & Lomb.

James is married to Hilary and they have two young Jedi warriors, Ruaridh and Iona.  Whilst at Heriot-Watt University he along with a small band of renegades deployed the ‘ultimate weapon’ and founded the Heriot-Watt University Pipe Band.  James is also a member of the Royal Scottish Pipers’ Society.

Ken Sutherland PhD
President, Canon Medical Research Europe Ltd 

 

Ken currently holds the position of Company President of Canon Medical Research Europe (formerly Toshiba Medical) in Edinburgh with responsibility for a large team of computer scientists, data analysts and clinical experts.  This group is responsible for research and development of novel clinical applications for 3D medical imaging as part of the Canon Corporation.

The team in Edinburgh collaborates with a number of practicing clinicians and academic researchers in the UK and across Europe and is focused on bringing new innovation into the Canon Medical product line.  In this post Ken is part of Canon Medical’s Global R&D leadership and serves as an industry advisory to the Scottish Government on the Life Sciences Industry Leadership Group.  Ken also holds the position of Chair of the Scottish Lifesciences Association, a trade body for the industry in Scotland.

Ken returned to Edinburgh in August 2007 to join Toshiba as R&D General Manager having previously held the post of Operations Director for a European multinational running its imaging R&D facility in Cambridge, England.  Ken studied Electronics and Computer Science at Edinburgh University and has a PhD in Data Sciences and four years postdoctoral research experience in medical image analysis and machine learning.

Derek Shaw 
Head of Investment Management, Scottish Investment Bank 

 

Derek is Head of Investment Management within the Scottish Investment Bank (SIB), the investment arm of Scottish Enterprise (SE).

Derek leads the teams responsible for SIB’s Portfolio Management, Compliance & Risk Management and Business Support functions.

The role of SIB is to grow Scotland’s private sector funding market, ensuring both early stage and established SMEs with growth and exporting potential have adequate access to growth capital to reach their full potential. The Portfolio Management team manages SE’s portfolio of commercial investments across SIB’s equity funds that consists of 280 companies valued at c£260m.

Derek also oversees the team responsible for delivery of the compliance, risk management and business supports functions within SIB. Derek joined SE from Bank of Scotland where he was Associate Director having spent eight years in a variety of roles within the Corporate Banking division, including within the equity investment and high growth start-up teams.

Andrew Henderson BEng, MBA 
Team Leader – High Value Manufacturing & Health, Scottish Enterprise 

 

Andrew leads a team which works closely with industry, academic, healthcare and Government partners to develop and deliver strategies to support the growth of the Life & Chemical Sciences industry in Scotland, with a specific focus on manufacturing, medical devices, pharmaceutical services and regenerative medicine.

Andrew has also worked with the Scottish Investment Bank, leading a programme to boost equity investment in Scottish companies.  Prior to this, Andrew was Programme Leader for Scottish Enterprise’s flagship Life Science project – the Edinburgh BioQuarter.  In over 15 years at SE, he has been responsible for developing the Scottish Centre for Regenerative Medicine and the development of a national strategy for regenerative medicine with industry stakeholders.

Andrew has been a director of Roslin Cells Ltd, a founder and Director of the Scottish Stem Cell Network, and a Director of Scottish Health Innovations Ltd – which works in partnership with NHS Scotland to protect and develop new innovations which come from NHS Scotland’s Health professionals.

Prior to Scottish Enterprise, Andrew spent over 10 years working for high-profile Scottish medical device start-ups, including Optos and Voxar (now Toshiba Medical Visualisation Systems), in a variety of engineering, product development, marketing and management roles – working with some of the world’s biggest medical companies.

Andrew has a Bachelor of Engineering degree in electronics & software engineering from Edinburgh’s Heriot-Watt University, and an MBA from the University of Edinburgh’s Business School.